Valuable medtech innovation during a pandemic

The Coronavirus (COVID-19) outbreak has demonstrated the need for a novel treatment for benign prostate enlargement (BPE) and chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS). Their standard treatments with medications and surgeries require extensive contact between patients and healthcare professionals, that worsens the pandemic.

Dr Allen’s Device and Thermobalancing therapy enable an effective at-home treatment, which relieves chronic pelvic pain and urinary symptoms, and reduces an abnormal prostate size, improving men’s quality of life and wellbeing.

This remarkable healthcare innovation allows to minimise exposure to coronavirus and other infections, which is important during the coronavirus pandemic.

More information about this novel medical technology is published in Medico Research Chronicles. You can read and download the article here for free: